Vizz™ (aceclidine) – New drug approval
July 31, 2025 - LENZ Therapeutics announced the FDA approval of Vizz (aceclidine), for the treatment of presbyopia in adults.
July 31, 2025 - LENZ Therapeutics announced the FDA approval of Vizz (aceclidine), for the treatment of presbyopia in adults.